Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shandong Shengyuan Peptide Technology

Shandong Shengyuan Peptide Technology

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Shandong Shengyuan Peptide Technology between 17 Oct 2025 and 25 Nov 2025. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
Shandong Shengyuan Peptide Technology
Tirzepatide
Tested 6 Samples
Last test 25 Nov 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Shandong Shengyuan Peptide Technology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG8.4MIN5.7MAX10.0

Last

25 Nov 2025

First

17 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
25 Nov 2025View5.75mg4.78mg-4.4%98.70%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab EPublic
18 Nov 2025View8.030mg30.1mg+0.3%99.94%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
17 Nov 2025View9.415mg15.1mg+0.7%99.65%TR-OCT25-BLUEWhite Label / Silver Crimp / Blue CapLab EPublic
17 Oct 2025View9.210mg9.26mg-7.4%99.95%9242025WHITE(no data)Lab EPublic
17 Oct 2025View10.030mg30.5mg+1.7%99.95%9242025CLEAR(no data)Lab EPublic
17 Oct 2025View8.020mg22.4mg+12.0%99.95%9242025GRAY(no data)Lab EPublic